Cargando…
Identifying Differentially Expressed MicroRNAs, Target Genes, and Key Pathways Deregulated in Patients with Liver Diseases
Liver diseases are important causes of morbidity and mortality worldwide. The aim of this study was to identify differentially expressed microRNAs (miRNAs), target genes, and key pathways as innovative diagnostic biomarkers in liver patients with different pathology and functional state. We determin...
Autores principales: | Gholizadeh, Maryam, Szelag-Pieniek, Sylwia, Post, Mariola, Kurzawski, Mateusz, Prieto, Jesus, Argemi, Josepmaria, Drozdzik, Marek, Kaderali, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582243/ https://www.ncbi.nlm.nih.gov/pubmed/33036164 http://dx.doi.org/10.3390/ijms21197368 |
Ejemplares similares
-
Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failure
por: Szeląg-Pieniek, Sylwia, et al.
Publicado: (2021) -
Gene Expression and Protein Abundance of Hepatic Drug Metabolizing Enzymes in Liver Pathology
por: Drozdzik, Marek, et al.
Publicado: (2021) -
Monocarboxylate Transporter 1 (MCT1) in Liver Pathology
por: Droździk, Marek, et al.
Publicado: (2020) -
Protein Abundance of Drug Transporters in Human Hepatitis C Livers
por: Droździk, Marek, et al.
Publicado: (2022) -
Protein Abundance of Drug Metabolizing Enzymes in Human Hepatitis C Livers
por: Drozdzik, Marek, et al.
Publicado: (2023)